OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Quell Therapeutics - Opportunities and Challenges in Biotech, 2024
Quell Therapeutics is a London, UK based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date:
18 January 2024, 12:00
Venue:
IMS-Tetsuya Nakamura Building, Roosevelt Dr, Headington OX3 7TY
Venue Details:
Ground Floor Seminar Room - followed by lunch and networking. Also available via Zoom.
Speaker:
Luke Devey (Vice President, Head of Translational Science, Immunology)
Organising department:
Medical Sciences Office
Organisers:
Sheena Lee (MSD Business Partnerships Office),
Dr Charlotte Bell (University of Oxford),
Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address:
sheena.lee@medsci.ox.ac.uk
Hosts:
Sheena Lee (MSD Business Partnerships Office),
Dr Charlotte Bell (University of Oxford)
Part of:
Industry Insight Seminar Series
Booking required?:
Required
Booking url:
https://forms.office.com/e/suZ1J5CiU1
Cost:
Free
Audience:
Public
Editor:
Sheena Lee
